发明名称 Therapeutic uses of allogeneic myeloid progenitor cells
摘要 Myeloid function is enhanced by transplantation or infusion of allogeneic myeloid progenitor cells, including CMP, GMP, MEP and MKP cell subsets. Myeloid progenitors ameliorate sequelae of anemia and thrombocytopenia, and can prevent or treat gastrointestinal mucositis associated with chemotherapy, radiotherapy, and the like. The transplantation or infusion may be performed in the absence of HLA typing, and the cells may be mismatched at one or more Class I HLA loci. The transplantation may provide for treatment of ongoing disease, or prevention of disease in high risk patients.
申请公布号 US8980329(B2) 申请公布日期 2015.03.17
申请号 US201012875022 申请日期 2010.09.02
申请人 The Board of Trustees of the Leland Stanford Junior University 发明人 Brown Janice Marie
分类号 A61K35/26;C12N5/00;C12N5/08;C12N5/02;A61K38/19;A61K38/18 主分类号 A61K35/26
代理机构 Bozicevic, Field & Francis LLP 代理人 Bozicevic, Field & Francis LLP ;Sherwood Pamela J.
主权项 1. A method of providing myeloid function in a individual in need thereof, said method comprising: transplanting into said individual a biologically effective dose of allogeneic myeloid progenitor cells.
地址 Palo Alto CA US